Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer
-
By
-
Muhammad Talal Amin
-
Louis Coussement
-
Tim De Meyer
-
June 9, 2026
-
Clinical Scorecard: Emerging Approaches and Challenges in Genome-Wide Assessment of Loss of Imprinting in Cancer
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Epigenetic regulation via DNA methylation and Imprinting Control Regions (ICRs) - ensure this is directly sourced. |
| Target Population | |
| Care Setting | |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
- Emerging clinical test strategies targeting imprinting loss are being developed - ensure this is directly sourced.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Patients with cancer exhibiting dysregulated imprinting patterns.
Clinical tests targeting imprinting loss are in development.
Clinical Best Practices
Related Resources & Content
